FDA Revises Project to Ease Drug Name Confusion

Drug Industry Daily
A A
The FDA will make reviews of promotional materials optional for participants in its pilot project to help reduce the potential for medication errors caused by confusion over similar proprietary drug names.

To View This Article:

Login

Subscribe To Drug Industry Daily